Corbus Pharmaceuticals Holdings, Inc. (CRBP) Free cash flow 2016–2025
Corbus Pharmaceuticals Holdings, Inc. (CRBP) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$64.5MFY2025 · since FY2016: -$13.9M → -$64.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$64.5M | -54.3% |
| FY2024 | -$41.8M | -15.8% |
| FY2023 | -$36.1M | +3.9% |
| FY2022 | -$37.6M | +22.1% |
| FY2021 | -$48.2M | +51.8% |
| FY2020 | -$100.2M | -106.7% |
| FY2019 | -$48.5M | -49.7% |
| FY2018 | -$32.4M | -13.6% |
| FY2017 | -$28.5M | -104.7% |
| FY2016 | -$13.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CRBP financial trends
CRBP RevenueCRBP Net incomeCRBP Net marginCRBP Gross profitCRBP Gross marginCRBP Operating incomeCRBP Operating marginCRBP Operating cash flowCRBP Capital expendituresCRBP Return on equityCRBP Stock buybacksCRBP Dividends paidCRBP Total assetsCRBP Total liabilitiesCRBP Shareholders’ equityCRBP overview →